An olaparib resistant cell line was generated from UWB1 cells that were treated with sustained, physiologically relevant 1μM concentrations of olaparib-containing cell media for 21 days to produce an olaparib-resistant, BRCA1 mutant ovarian cancer cell line named UWB1-R. Here, BRCA1 is linked to ovarian carcinoma.